| Community Health Centers Lompoc | |
|
1300 W Ocean Ave Lompoc CA 93436-5678 | |
| (805) 737-1169 | |
| (805) 737-1772 |
| Full Name | Community Health Centers Lompoc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1300 W Ocean Ave, Lompoc, California |
| Authorized Official Name and Position | Barbara Allen (DIRECTOR OF BUSINESS OFFICE) |
| Authorized Official Contact | 8053618014 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Community Health Centers Lompoc 2050 S Blosser Rd Santa Maria CA 93458-7310 Ph: (805) 361-8014 | Community Health Centers Lompoc 1300 W Ocean Ave Lompoc CA 93436-5678 Ph: (805) 737-1169 |
| NPI Number | 1326065103 |
|---|---|
| Provider Enumeration Date | 07/16/2006 |
| Last Update Date | 12/12/2023 |
| Medicare PECOS PAC ID | 7416868120 |
|---|---|
| Medicare Enrollment ID | O20050804001109 |
News Archive
A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.
Scientists have moved a step closer to being able to preserve fertility in young boys who undergo chemotherapy and radiation treatments for cancer. The new research, published in Fertility and Sterility, the journal of the American Society for Reproductive Medicine, addresses the safety of an option scientists are developing for boys who aren't sexually mature and cannot bank sperm.
A leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.
QIAGEN today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326065103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
A team of international scientists has recently determined the association between gout and risk of coronavirus disease 2019 (COVID-19) related death in a large cohort of patients. Their findings reveal that gout can significantly increase the risk of COVID-19 and related mortality, with women having a higher risk than men. The study is currently available on the medRxiv* preprint server.
Scientists have moved a step closer to being able to preserve fertility in young boys who undergo chemotherapy and radiation treatments for cancer. The new research, published in Fertility and Sterility, the journal of the American Society for Reproductive Medicine, addresses the safety of an option scientists are developing for boys who aren't sexually mature and cannot bank sperm.
A leading developer in the treatment of multiple sclerosis (MS), today announced that the independent Data Safety Monitoring Board (DSMB) has reviewed data from the Company's on-going MAESTRO-03 U.S. pivotal phase III clinical trial of MBP8298 for the treatment of secondary progressive MS and recommended that the trial continue.
QIAGEN today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.
A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology.
› Verified 5 days ago
Lompoc Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 301 N R St, Lompoc, CA 93436 Phone: 805-737-6400 Fax: 805-737-6458 | |
Rahim A Raoufi, Md Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 228 S D St, Suite B, Lompoc, CA 93436 Phone: 208-667-9334 Fax: 208-664-2341 | |
Lompoc Valley Medical Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 303 South C Street, Lompoc, CA 93436 Phone: 805-737-3321 Fax: 805-737-3389 | |
Central Coast Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1101 E Ocean Ave, Suite B, Lompoc, CA 93436 Phone: 805-740-9400 Fax: 805-741-2640 | |
Urgent Care Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 217 W Central Ave, Suite G, Lompoc, CA 93436 Phone: 805-735-4292 Fax: 805-735-4293 | |
Santa Barbara County Public Health Dept-lompoc Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 301 N R St, Lompoc, CA 93436 Phone: 805-737-6400 Fax: 805-737-6425 |